<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7551450/table_12" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 12</label>
  <p>Studies on the design of antiviral agents based on the structure and function of viral and human receptor proteins in Korea (Sub-Cluster 2-2).</p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">NO</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Organization</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Title</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-3-.">Estimated Average Cost/Fiscal Year (USD)</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-4-.">Estimated Total Cost (USD)</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-5-.">Start Date</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-6-.">End Date</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Institut Pasteur Korea</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preparedness of Emerging Viruses</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500,035</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3,000,210</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 June 2017</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31 December 2022</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ilyang Pharmaceutical Co., Ltd.</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deriving new candidates for the development of therapeutics in the Middle East Respiratory Syndrome</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">152,727</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">763,636</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 July 2016</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31 March 2021</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hallym University</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Development of therapeutic target and candidate for immunotherapy against middle east respiratory syndrome coronavirus (MERS-CoV)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83,636</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">418,182</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 July 2016</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31 March 2021</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Korea Advanced Institute of Science and Technology</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Development of novel therapeutics for infectious diseases through activation of innate immune system</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">178,182</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">356,364</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 November 2015</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31 October 2017</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chonbuk National University</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Development of recombinant subunit vaccine candidates for the protection against MERS-CoV infection</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68,182</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">272,727</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 December 2015</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 November 2019</td>
  </tr>
 </tbody>
</table>
